Timeline
Regeneron
US biotech that developed Inmazeb, the Zaire ebolavirus monoclonal cocktail with no approved Bundibugyo efficacy.
2 of 2 entries (2 events, 0 interactions)
Filters
#7 12 Jun
Developed REGN3479 monoclonal antibody now in the Bundibugyo treatment trial
Pandemics and Biosecurity: First Ebola treatment trial goes live#3 17 May